The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
Open accessAbstract
SUMMARY: The increased use of antibacterial and antifungal agents in recent years has resulted in the development of resistance to these drugs. The significant clinical implication of resistance has led to heightened interest in the study of antimicrobial resistance from different angles. Areas addressed include mechanisms underlying this resistance, improved methods to detect resistance when it occurs, alternate options for the treatment of infections caused by resistant organisms, and strategies to prevent and control the emergence and spread of resistance. In this review, the mode of action of antifungals and their mechanisms of resistance are discussed. Additionally, an attempt is made to discuss the correlation between fungal and bacterial resistance. Antifungals can be grouped into three classes based on their site of action: azoles, which inhibit the synthesis of ergosterol (the main fungal sterol); polyenes, which interact with fungal membrane sterols physicochemically; and 5-fluorocytosine, which inhibits macromolecular synthesis. Many different types of mechanisms contribute to the development of resistance to antifungals. These mechanisms include alteration in drug target, alteration in sterol biosynthesis, reduction in the intercellular concentration of target enzyme, and overexpression of the antifungal drug target. Although the comparison between the mechanisms of resistance to antifungals and antibacterials is necessarily limited by several factors defined in the review, a correlation between the two exists. For example, modification of enzymes which serve as targets for antimicrobial action and the involvement of membrane pumps in the extrusion of drugs are well characterized in both the eukaryotic and prokaryotic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Cohen, M. L. (1992) · Science · doi:10.1126/science.257.5073.1050 · Cited by 1,304
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Amphotericin B: 30 Years of Clinical Experience
Gallis, H. A., Drew, R. H., & Pickard, W. W. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.308 · Cited by 1,009
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Self-citationHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)
Kahan, F. M., Kahan, J. S., Cassidy, P. J., & Kropp, H. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb43277.x · Cited by 777
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
De Kruijff, B., & Demel, R. A. (1974) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(74)90332-0 · Cited by 609
Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action
Edwards, D. I. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.1.9 · Cited by 606
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Glycopeptide resistance in enterococci
ARTHUR, M., REYNOLDS, P., & COURVALIN, P. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10063-9 · Cited by 414
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402
Cohen, S. P., Hächler, H., & Levy, S. B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.5.1484-1492.1993 · Cited by 388
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Studies on antibiotic synergism against enterococci
Moellering, R. C., & Weinberg, A. N. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106758 · Cited by 302
Studies on the Biological Properties of Polyene Antibiotics
Norman, A. W., Demel, R. A., de Kruyff, B., & van Deenen, L. L. M. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45558-0 · Cited by 299
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1488 · Cited by 292
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Van Den Bossche, H., Willemsens, G., Cools, W., Lauwers, W. F. J., & Le Jeune, L. (1978) · Chemico-Biological Interactions · doi:10.1016/0009-2797(78)90068-6 · Cited by 281
Li, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Chemistry and biology of the polyene macrolide antibiotics.
Hamilton-Miller, J. M. T. (1973) · Bacteriological Reviews · doi:10.1128/mmbr.37.2.166-196.1973 · Cited by 274
Redding, S., Smith, J., Farinacci, G., Rinaldi, M., Fothergill, A., Rhine-Chalberg, J., & Pfaller, M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.240 · Cited by 269
Mode of action of 5-fluorocytosine and mechanisms of resistance
Polak, A., & Scholer, H. J. (2009) · Chemotherapy · doi:10.1159/000221854 · Cited by 250 · cited 2×
“albicans and Cryptococcus neoformans is attributable to mutational loss of one of the pyrimidine salvage enzymes (99, 108, 150).”
BackgroundCompounds active against cell walls of medically important fungi
Hector, R. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.1 · Cited by 242
Incidence of polyene-resistant yeasts recovered from clinical specimens
Dick, J. D., Merz, W. G., & Saral, R. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.1.158 · Cited by 242
Human Mycoses: Drugs and Targets for Emerging Pathogens
Georgopapadakou, N. H., & Walsh, T. J. (1994) · Science · doi:10.1126/science.8153622 · Cited by 232
Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms
Medoff, G., Comfort, M., & Kobayashi, G. S. (1971) · Experimental Biology and Medicine · doi:10.3181/00379727-138-35943 · Cited by 223
Sanati, H., Belanger, P., Fratti, R., & Ghannoum, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2492 · Cited by 221
Self-citationMechanism of Fluconazole Resistance in Candida krusei
Orozco, A. S., Higginbotham, L. M., Hitchcock, C. A., Parkinson, T., Falconer, D., Ibrahim, A. S., Ghannoum, M. A., & Filler, S. G. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2645 · Cited by 218 · cited 1×
“albicans, suggesting that affinity of the target enzyme is different in the two species (101).”
BackgroundSelf-citationLipopeptide inhibitors of fungal glucan synthase
Kurtz, M. B., & Douglas, C. M. (1997) · Medical Mycology · doi:10.1080/02681219780000961 · Cited by 216
Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.
Lopez-Berestein, G., Bodey, G. P., Frankel, L. S., & Mehta, K. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.2.310 · Cited by 216
Geber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., & Bennett, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2708 · Cited by 203
Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS
Larsen, R. A., Bozzette, S. A., Jones, B. E., Haghighat, D., Leal, M. A., Forthal, D., Bauer, M., Tilles, J. G., McCutchan, J. A., & Leedom, J. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.4.741 · Cited by 203
Characterization of an azole-resistant Candida glabrata isolate
vanden Bossche, H., Marichal, P., Odds, F. C., Le Jeune, L., & Coene, M. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2602 · Cited by 203
Lamb, D. C., Kelly, D. E., Schunck, W.-H., Shyadehi, A. Z., Akhtar, M., Lowe, D. J., Baldwin, B. C., & Kelly, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5682 · Cited by 193
Hitchcock, C. A., Dickinson, K., Brown, S. B., Evans, E. G. V., & Adams, D. J. (1990) · Biochemical Journal · doi:10.1042/bj2660475 · Cited by 190
SAMARANAYAKE, Y. H., & SAMARANAYAKE, L. P. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-5-295 · Cited by 190
Genetic and Physiological Aspects of Resistance to 5-Fluoropyrimidines in Saccharomyces cerevisiae
Jund, R., & Lacroute, F. (1970) · Journal of Bacteriology · doi:10.1128/jb.102.3.607-615.1970 · Cited by 187
In vitro and in vivo evaluation of antifungal agents
Espinel-Ingroff, A., & Shadomy, S. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963469 · Cited by 179
VAN DEN BOSSCHE, H., WILLEMSENS, G., COOLS, W., MARICHAL, P., & LAUWERS, W. (1983) · Biochemical Society Transactions · doi:10.1042/bst0110665 · Cited by 173
Anaissie, E., & Bodey, G. P. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30311-1 · Cited by 159
Nitroimidazole drugs - action and resistance mechanisms II. Mechanisms of resistance
Edwards, D. I. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.2.201 · Cited by 153
Traxler, P. M., Gruner, J., & Auden, J. A. L. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.289 · Cited by 151
Brockman, E. W. (1974) · Springer eBooks · doi:10.1007/978-3-642-65678-1_19 · Cited by 148
MECHANISM OF PROTECTION BY STEROLS AGAINST POLYENE ANTIBIOTICS
Lampen, J. O., Arnow, P. M., & Safferman, R. S. (1960) · Journal of Bacteriology · doi:10.1128/jb.80.2.200-206.1960 · Cited by 147
Protection of Fungi against Polyene Antibiotics by Sterols
GOTTLIEB, D., Carter, H. E., Sloneker, J. H., & Ammann, A. (1958) · Science · doi:10.1126/science.128.3320.361 · Cited by 144
Pangon, B., Bizet, C., Buré, A., Pichon, F., Philippon, A., Regnier, B., & Gutmann, L. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.1005 · Cited by 142
Mode of action of 5-fluorocytosine
Diasio, R. B., Bennett, J. E., & Myers, C. E. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90507-5 · Cited by 141
Witt, M. D., Lewis, R. J., Larsen, R. A., Milefchik, E. N., Leal, M. A. E., Haubrich, R., Richie, J., Edwards, J. E., & Ghannoum, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.322 · Cited by 136
Self-citationResistance of Enterococci to Aminoglycosides and Glycopeptides
Leclercq, R., Dutka‐Malen, S., Brisson-Noël, A., Molinas, C., Derlot, E., Arthur, M., Duval, J., & Courvalin, P. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.495 · Cited by 134
Kelly, S. L., Lamb, D. C., Taylor, M., Corran, A. J., Baldwin, B. C., & Powderly, W. G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07140.x · Cited by 133
Sullivan, P. A., Chiew, Y. Y., Molloy, C., Templeton, M. D., & Shepherd, M. G. (1983) · Canadian Journal of Microbiology · doi:10.1139/m83-233 · Cited by 132
Polyene Resistance and the Isolation of Sterol Mutants in Saccharomyces cerevisiae
Molzahn, S. W., & Woods, R. A. (1972) · Journal of General Microbiology · doi:10.1099/00221287-72-2-339 · Cited by 132
Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata
Parkinson, T., Falconer, D. J., & Hitchcock, C. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1696 · Cited by 129
Emerging Targets in Antibacterial and Antifungal Chemotherapy
Sutcliffe, J. A., & Georgopapadakou, N. H. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3274-3 · Cited by 127
Fontana, R., Aldegheri, M., Ligozzi, M., López, H. M., Sucari, A., & Satta, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.1980 · Cited by 125
The Development Of Resistance By Candida Species To Polyene Antibiotics In Vitro
Athar, M. A., & Winner, H. I. (1971) · Journal of Medical Microbiology · doi:10.1099/00222615-4-4-505 · Cited by 123
Zhou, X. Y., Bordon, F., Sirot, D., Kitzis, M.-D., & Gutmann, L. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1085 · Cited by 121
Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in Mice
Polak, A., Scholer, H. J., & Wall, M. (2009) · Chemotherapy · doi:10.1159/000238138 · Cited by 118
Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.
Juliano, R. L., Grant, C. W. M., Barber, K. R., & Kalp, M. A. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10311-8 · Cited by 118
Mechanisms of Action of the Antimycotic Imidazoles
Sud, I. J., & Feingold, D. S. (1981) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12521036 · Cited by 117
Evidence for a Glycosidic Linkage between Chitin and Glucan in the Cell Wall of Candida albicans
Surarit, R., Gopal, P. K., & Shepherd, M. G. (1988) · Microbiology · doi:10.1099/00221287-134-6-1723 · Cited by 107
Fungal Protoplasts: Applications in Biochemistry and Genetics
Peberdy, J. F. (1985) · Medical Entomology and Zoology · Cited by 104
BOSSCHE, H. V., Marichal, P., Jeune, L. L., Coene, M. C., Gorrens, J., & Cools, W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2101 · Cited by 103
Chemistry and biology of the polyene macrolide antibiotics
Hamilton-Miller, J. M. T. (1973) · Bacteriological Reviews · doi:10.1128/br.37.2.166-196.1973 · Cited by 103
Azole resistance inCandida albicans
Smith, K. J., Warnock, D. W., Kennedy, C., Johnson, E. M., Hopwood, V., Cutsem, J. V., & BOSSCHE, H. V. (1986) · Medical Mycology · doi:10.1080/02681218680000201 · Cited by 103
Stiller, R. L., Bennett, J. E., Scholer, H. J., Wall, M., Polak, A., & Stevens, D. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.3.482 · Cited by 102
Clark, F. S., Parkinson, T., Hitchcock, C. A., & Gow, N. A. R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.419 · Cited by 101
In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrata
Normark, S. J., & Schönebeck, J. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.3.114 · Cited by 100
Mizoguchi, J., Saito, T., Mizuno, K., & Hayano, K. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.308 · Cited by 100
Cassone, A., Kerridge, D., & Gale, E. F. (1979) · Journal of General Microbiology · doi:10.1099/00221287-110-2-339 · Cited by 100
THE EFFECTS OF THE POLYENE ANTIBIOTICS NYSTATIN AND AMPHOTERICIN B ON THIN LIPID MEMBRANES
Holz, R. W. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb43284.x · Cited by 98
Amphotericin B nephrotoxicity: Increased renal resistance and tubule permeability
Cheng, J.-T., Witty, R. T., Robinson, R. R., Yarger, W. E., Schrader, W. T. T. A. O. N. W., & Kennedy, B. M. (1982) · Kidney International · doi:10.1038/ki.1982.221 · Cited by 92
The Genetic Basis of Resistance to 5-Fluorocytosine in Candida Species and Cryptococcus Neoformans
Whelan, W. L. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104447 · Cited by 88
Poulain, D., Tronchin, G., Jf, D., & Biguet, J. (1978) · PubMed · Cited by 87
Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans
Ryder, N. S., Seidl, G., & Troke, P. F. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.4.483 · Cited by 85
Lysis of growing yeast-form cells ofCandida albicansby echinocandin: A cytological study
Cassone, A., Mason, R. E., & Kerridge, D. (1981) · Medical Mycology · doi:10.1080/00362178185380161 · Cited by 82
Hitchcock, C. A., Barrett-Bee, K. J., & Russell, N. J. (1987) · Medical Mycology · doi:10.1080/02681218780000041 · Cited by 80
Factors Affecting the Changes in Amphotericin Sensitivity of Candida albicans during Growth
Gale, E. F., Johnson, A. M., Kerridge, D., & Koh, T. Y. (1975) · Journal of General Microbiology · doi:10.1099/00221287-87-1-20 · Cited by 75
CLINICAL RELEVANCE OF ANTIFUNGAL RESISTANCE
Espinel‐Ingroff, A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70398-6 · Cited by 71
Chopra, A., & Khuller, G. K. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90009-7 · Cited by 64
Fluconazole versus Candida albicans : A Complex Relationship
Graybill, J. R., Montalbo, E. M., Kirkpatrick, W. R., Luther, M. F., Revankar, S. G., & Patterson, T. F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2938 · Cited by 64
Belanger, P. H., Nast, C. C., Fratti, R. A., Sanati, H., & Ghannoum, M. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1840 · Cited by 64
Self-citationSequence Comparison of Yeast ATP-binding Cassette ProteinsPreprint
Michealis, S., & Berkower, C. (1995) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1995.060.01.034 · Cited by 63
Chemotherapeutic Activity of 5-Fluorocytosine and Amphotericin B Against Candida albicans in Mice
Titsworth, E. H., & Grunberg, E. (1973) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.4.3.306 · Cited by 62
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole
Ghannoum, M. A., Spellberg, B. J., Ibrahim, A. S., Ritchie, J. A., Currie, B., Spitzer, E. D., Edwards, J. E., & Casadevall, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2029 · Cited by 60
Self-citationLiposome-Encapsulated Amphotericin B: A Promising New Treatment for Disseminated Fungal Infections
Wiebe, V. J., & DeGregorio, M. W. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.6.1097 · Cited by 60
Sterol biosynthesis in antibiotic-resistant yeast: Nystatin
Fryberg, M., Oehlschlager, A. C., & Unrau, A. M. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(74)80011-1 · Cited by 59
Synergistic Action of Amphotericin Band Rifampin against Candida Species
Beggs, W. H., Sarosi, G. A., & Walker, M. I. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.2.206 · Cited by 59
Defever, K. S., Whelan, W. L., Rogers, A. L., Beneke, E. S., Veselenak, J. M., & Soll, D. R. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.810 · Cited by 53
Whelan, W. L., & Kerridge, D. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.570 · Cited by 53
Walsh, T. J., Lee, J. W., Kelly, P., Bacher, J. D., Lecciones, J., Thomas, V. M., Lyman, C. A., Coleman, D. L., Gordee, R. S., & Pizzo, P. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1321 · Cited by 50
Sequence of the Candida albicans erg7 gene
Roessner, C. A., Min, C., Hardin, S. H., Harris-Haller, L. W., McCollum, J. C., & Scott, A. L. (1993) · Gene · doi:10.1016/0378-1119(93)90631-c · Cited by 49
Drug resistance in human pathogenic fungi
Iwata, K. (1992) · European Journal of Epidemiology · doi:10.1007/bf00158576 · Cited by 48
Payne, N. I., Cosgrove, R. F., Green, A. P., et al. (1987) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1987.tb07156.x · Cited by 42
Ghannoum, M. A., Okogbule-Wonodi, I., Bhat, N., & Sanati, H. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.1.34 · Cited by 42
Self-citationGlucan Biosynthesis in Fungi and its Inhibition
Tkacz, J. S. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3274-3_19 · Cited by 40
Rapid Emergence of Resistance to Cefepime During Treatment
Limaye, A. P., Gautom, R., Black, D. J., & Fritsche, T. R. (1997) · Clinical Infectious Diseases · doi:10.1086/516917 · Cited by 40
Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans
Pfaller, M. A., Riley, J., & Koerner, T. A. W. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975172 · Cited by 39
Walsh, T. J., Kasai, M., Francesconi, A., Landsman, D., & Chanock, S. J. (1997) · Medical Mycology · doi:10.1080/02681219780001021 · Cited by 38
Levy, S. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008023230509 · Cited by 31
Anaissie, E. J., Hachem, R. Y., Tin-U, C., Stephens, L. C., & Bodey, G. P. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1268-1271.1993 · Cited by 30
Resistance to antifungal agents in the critical care setting: problems and perspectives.
Martins, & Rex, J. H. (1996) · PubMed · Cited by 30
Bozzola, J. J., MEHTA, R. J., Nisbet, L. J., & Valenta, J. R. (1984) · Canadian Journal of Microbiology · doi:10.1139/m84-133 · Cited by 29
Comparison of miconazole– and ketoconazole–induced release of K+ from Candida species
Beggs, W. H. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/11.4.381 · Cited by 22
Fatal disseminated cryptococcosis following intraocular involvement.
Schulman, J. A., Leveque, C. M., Coats, M., Lawrence, L., & Barber, J. C. (1988) · British Journal of Ophthalmology · doi:10.1136/bjo.72.3.171 · Cited by 19
Beggs, W. H., Andrews, F. A., & Sarosi, G. A. (2009) · Chemotherapy · doi:10.1159/000237987 · Cited by 17
Sensitivity of Candida albicans to amphotericin B administered as single or fractionated doses
Sokol-Anderson, M. L., Brajtburg, J., & Medoff, G. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.701 · Cited by 13
Cited by
Hyldgaard, M., Mygind, T., & Meyer, R. L. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00012 · Cited by 2,191
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
The biology and chemistry of antifungal agents: A review
Kathiravan, M. K., Salake, A. B., Chothe, A. S., Dudhe, P. B., Watode, R. P., Mukta, M. S., & Gadhwe, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.045 · Cited by 664
Borkovich, K. A., Alex, L. A., Yarden, O., Freitag, M., Turner, G. E., Read, N. D., Seiler, S., Bell-Pedersen, D., Paietta, J., Plesofsky, N., et al. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.1.1-108.2004 · Cited by 621
Metadata
- Authors
- Ghannoum, M. A., & Rice, L. B.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1999-10
- Volume
- 12
- Issue
- 4
- Pages
- 501-517
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2144149632
- Cited by
- 1,785
- References
- 118
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.